Use Of N-(4-((3-(2-Amino-4-Pyrimidinyl)-2-Pyridinyl)Oxy)Phenyl)-4-(4-Methyl-2-Thienyl)-1-Phthalazinamine In The Treatment Of Antimitotic Agent Resistant Cancer
    1.
    发明申请
    Use Of N-(4-((3-(2-Amino-4-Pyrimidinyl)-2-Pyridinyl)Oxy)Phenyl)-4-(4-Methyl-2-Thienyl)-1-Phthalazinamine In The Treatment Of Antimitotic Agent Resistant Cancer 审中-公开
    N-(4 - ((3-(2-氨基-4-嘧啶基)-2-吡啶基)氧基)苯基)-4-(4-甲基-2-噻吩基)-1-酞嗪胺在抗疟药物的处理中的用途 耐药性癌症

    公开(公告)号:US20120028917A1

    公开(公告)日:2012-02-02

    申请号:US12878539

    申请日:2010-09-09

    CPC分类号: A61K31/502

    摘要: The present invention relates to methods of using the compound, N-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl) -1-phthalazinamine, to treat cancers, including solid tumors, which have become resistant to treatment with chemotherapeutic agents, including anti-mitotic agents such as taxanes, and/or other anti-cancer agents, including aurora kinase inhibiting agents. The invention also includes methods of treating cancers refractory to such treatments by administering a pharmaceutical composition, comprising the compound to a cancer subject.

    摘要翻译: 本发明涉及使用化合物N-(4 - ((3-(2-氨基-4-嘧啶基)-2-吡啶基)氧基)苯基)-4-(4-甲基-2-噻吩基) 1-酞嗪胺治疗已经变得对化学治疗剂(包括抗有丝分裂剂如紫杉烷类)和/或其它抗癌剂(包括极光激酶抑制剂)的治疗具有抗性的癌症,包括实体瘤。 本发明还包括通过向癌症受试者施用包含该化合物的药物组合物来治疗对这种治疗难治的癌症的方法。

    Heat exchanger
    2.
    发明授权

    公开(公告)号:US06408938B1

    公开(公告)日:2002-06-25

    申请号:US09051735

    申请日:1998-04-20

    IPC分类号: F28F1318

    摘要: An aluminum alloy containing (in wt. %): 0.2-0.5 Fe; 0.7-1.2 Si; 1.2-1.6 Mn; up to 0.3 Mg; up to 0.5 Cu; up to 0.2 Zn; up to 0.1 Ti is used to make the fins of heat exchangers particularly car radiators. The finstock has high post braze strength and thermal conductivity, and has a sufficiently electronegative potential as to be capable of acting as a sacrificial anode for the heat exchanger tubes. By virtue of the absence of Sn, In, and Cr, these heat exchangers can be scrapped and melted for re-use.

    Reconfigurable logic for a computer
    8.
    发明授权
    Reconfigurable logic for a computer 失效
    计算机的可重构逻辑

    公开(公告)号:US06438737B1

    公开(公告)日:2002-08-20

    申请号:US09505059

    申请日:2000-02-15

    IPC分类号: G06F1750

    CPC分类号: G06F15/7867

    摘要: A system is disclosed including a reconfigurable logic circuit having programmable logic, a first memory, and a second memory. The first memory stores a number of logic designs each operable to configure the programmable logic. Also included is a computer coupled to the reconfigurable logic circuit that concurrently executes one or more application programs and an interface program. The application programs generate a number of requests to utilize the reconfigurable logic circuit and the interface program responds to the requests by opening a number of coexisting program interfaces. These interfaces each correspond to an instance of one of the logic designs stored in the first memory. The reconfigurable logic circuit is responsive to the interface program to provide a number of interface buffers in the second memory that each belong to a corresponding one of the interfaces and are each operable to store data passing between the computer and the reconfigurable logic circuit.

    摘要翻译: 公开了一种包括具有可编程逻辑的可重构逻辑电路,第一存储器和第二存储器的系统。 第一存储器存储多个可用于配置可编程逻辑的逻辑设计。 还包括耦合到可重配置逻辑电路的计算机,其同时执行一个或多个应用程序和接口程序。 应用程序产生许多请求以利用可重构逻辑电路,并且接口程序通过打开多个共存程序接口来响应请求。 这些接口各自对应于存储在第一存储器中的逻辑设计之一的实例。 可重构逻辑电路响应于接口程序以在第二存储器中提供多个接口缓冲器,每个接口缓冲器各自属于对应的一个接口,并且每个可操作以存储在计算机和可重配置逻辑电路之间通过的数据。

    Method for performing a blood count and determining the morphology of a blood smear
    10.
    发明授权
    Method for performing a blood count and determining the morphology of a blood smear 有权
    用于进行血液计数并确定血液涂片形态的方法

    公开(公告)号:US08748186B2

    公开(公告)日:2014-06-10

    申请号:US12644410

    申请日:2009-12-22

    IPC分类号: G01N33/72

    摘要: A method for counting blood cells in a sample of whole blood. The method comprises the steps of: (a) providing a sample of whole blood; (b) depositing the sample of whole blood onto a slide, e.g., a microscope slide; (c) employing a spreader to create a blood smear; (d) allowing the blood smear to dry on the slide; (e) measuring absorption or reflectance of light attributable to the hemoglobin in the red blood cells in the blood smear on the slide; (f) recording a magnified two-dimensional digital image of the area of analysis identified by the measurement in step (e) as being of suitable thickness for analysis; and (g) collecting, analyzing, and storing data from the magnified two-dimensional digital image. Optionally, steps of fixing and staining of blood cells on the slide can be employed in the method.

    摘要翻译: 一种全血样品中血细胞计数的方法。 该方法包括以下步骤:(a)提供全血样品; (b)将全血样品沉积在载玻片上,例如显微镜载片上; (c)使用吊具产生血液涂片; (d)允许血液涂片在载玻片上干燥; (e)测量归因于载玻片上血液涂片中红细胞中血红蛋白的光的吸光度或反射率; (f)将通过步骤(e)中的测量识别的分析区域的放大二维数字图像记录为具有适于分析的厚度; 和(g)从放大的二维数字图像中收集,分析和存储数据。 任选地,可以在该方法中使用在载玻片上固定和染色血细胞的步骤。